Packaging-based visual-storytelling nudge to improve antibiotic adherence in uncomplicated urinary tract infection: a pilot randomized trial in Pakistan
Abstract
Antibiotic resistance (ABR) is a growing public health issue, where non-adherence to antibiotics accelerates the development of resistance. Packaging-based nudge interventions may offer a low-cost and scalable solution. This pilot randomized controlled trial (RCT) assessed the feasibility of a visual storytelling sticker affixed to antibiotic packaging to improve antibiotic adherence in patients with uncomplicated urinary tract infections (UTIs). A parallel two-arm pilot RCT was conducted across six tertiary-care hospitals between May and July 2025. Physician-confirmed uncomplicated UTI patients, prescribed with oral antibiotics, were randomized in a 1:1 manner to receive either antibiotics with a visual storytelling sticker (intervention) or standard care (control). Primary outcomes were feasibility metrics, including recruitment, retention, and intervention delivery fidelity. Antibiotic adherence, measured by pill count at the completion of treatment, was assessed as an exploratory outcome. Of the 120 patients approached, 114 were screened, and 84 were deemed eligible. Seventy patients consented, of whom 66 were randomized (33 per arm). The recruitment and retention rates were 61.4% and 84.8%, respectively, whereas the intervention delivery fidelity was 87.5%. Exploratory analysis showed a 14.3% improvement in adherence in the intervention group (63.3%, 95%CI 61.1–65.5) compared with the control group (49%, 95%CI 46.5–51.5), though the study was not powered to test…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 120 participants or records.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.